Fig. 2
From: BIRC5 expression by race, age and clinical factors in breast cancer patients
Association between BIRC5-high, patient and tumor characteristics in CBCS and TCGA. Forest plot displaying relative frequency differences and 95% confidence intervals (left panel) and odds ratios (center and right panels) for patient age, race, estrogen receptor/progesterone receptor/Her2 receptor status, PAM50 subtype, stage and tumor size across BIRC5 expression categories in CBCS (left and center panels, red circles) and TCGA (right panel, blue circles). Reduced models were adjusted for age and race according to the CBCS randomized sampling design (solid circles), and additionally adjusted for tumor stage and estrogen receptor status in full models (open circles). RFD: relative frequency difference; OR: odds ratio; 95% CI: 95% confidence interval; ER: estrogen receptor; PR: estrogen receptor; Ref.: Referent; BIRC5 referent group = BIRC5-low for all models. Dashed line represents the null value for each model